Speakers & agenda

Oxford Symposia - 3rd Annual

OLIGO 2017 OXFORD:

Antisense & Therapeutic Nucleic Acids

10 April 2017, St Hilda's College, Oxford, UK

Twitter: @LPMHealthcare, #OligoOx17

Speakers & agenda

(subject to change)

Monday 10th April 2017 | Vernon Harcourt Room, The South Building | St Hilda’s College

0830: Registration, welcome coffee and networking

0900: Welcome and housekeeping


SESSION 1: Chemical design and modification

Wengel0915: Professor Jesper Wengel
Center Director, BioNEC – A VKR Center of Excellence FKF – University of Southern Denmark, Denmark

Title: Lipo-LNA: Lipophilic 2’-amino-LNA derivatives for design of antisense oligonucleotides


Brown0945: Professor Tom Brown
Professor of Nucleic Acid Chemistry, Department of Chemistry, University of Oxford, United Kingdom

Title: Chemical ligation of DNA, biocompatibility and applications of artificial backbones


Hollenstein1015: Dr Marcel Hollenstein
Group Leader, Institut Pasteur, Laboratory for Bioorganic Chemistry of Nucleic Acids, Department of Chemistry and Structural Biology, Paris, France

Title: Synthesis and biochemical characterization of modified nucleoside triphosphates for selection experiments


1045: Refreshment break


SESSION 2: Application

Muntoni1115: Professor Francesco Muntoni
Chair of Paediatric Neurology, UCL GOS Institute of Child Health, University College London, United Kingdom

Title: Antisense oligonucleotides to modify splicing in Duchenne muscular dystrophy and Spinal muscular atrophy


Zammit1145: Professor Peter S Zammit
Randall Division of Cell and Molecular Biophysics, King’s College London, United Kingdom

Title: Ameliorating pathogenesis in Facioscapulohumeral muscular dystrophy by increasing SMCHD1 levels using saRNA


Blakey

1215: Dr David Blakey
Chief Scientific Officer, MiNA Therapeutics, United Kingdom

Title: Mechanism and in vivo activity of a small activating RNA targeting CEBPA, a novel therapeutic in clinical trials for liver disease


1245: Lunch (provided)


SESSION 3: Delivery

Richardson1345: Dr Simon Richardson
Senior Lecturer, Biopharmaceutical Sciences, Faculty of Engineering & Science, University of Greenwich, London, United Kingdom

Title: A Further Evaluation of Attenuated Anthrax Toxin’s Application as an Antisense Delivery System


Aleku1415: Dr Manuela Aleku
Head of In-vivo Pharmacology – Drug Discovery, Silence Therapeutics GmbH, Berlin, Germany

Title: Therapeutic RNA delivery: into hepatocytes and beyond


Wells1445: Professor Dominic J Wells
Department of Comparative Biomedical Sciences, Royal Veterinary College, United Kingdom

Title: Delivery of peptide conjugated PMO: effects of dose, age and steroids on muscle physiology in the mdx mouse


SESSION 4: Modelling, Labelling and Detection

borthwick1515: Dr Duncan Borthwick
Scientist, Dynamic Biosensors GmbH, Martinsried, Germany

Title: Modelling the Kinetics of Oligo Hybridisation and Ligase Activity Using A Regenerating Biochip, switchSENSE® Technology


1535: Refreshment break


Penedo1600: Dr Carlos Penedo
Principal Investigator, SUPA School of Physics and Astronomy, Biomedical Science Research Complex, University of St Andrews, United Kingdom

Title: Site-specific FRET-labelling of nascent RNA sequences within transcription complexes


Ladame1630: Dr Sylvain Ladame
Senior Lecturer and Deputy Director of Postgraduate Studies, Department of Bioengineering, Imperial College London, United Kingdom

Title: Subnanomolar Detection of Oligonucleotides via Templated Fluorogenic Reaction in Hydrogels: Controlling Diffusion to Improve Sensitivity


Miller1700: Professor Andrew Miller
Professor of Biochemistry, King’s College London & Chief Scientific Officer at GlobalAcorn, London, United Kingdom

Title: TBA


Tanner1730: Dr Julian A Tanner
Associate Professor and Coordinator of Education Division of Biochemistry, School of Biomedical Sciences at the University of Hong Kong, PR China

Title: Aptamers in DNA nanostructures as molecular sensing modules


1800: Discussion and close